Evidence map›Paper›PMID 31553758›Full record

ArticlePloS one2019

Risk factors for unsuccessful tuberculosis treatment outcomes in children.

Meherunissa Hamid, Meredith B Brooks, Falak Madhani, Hassan Ali, Mohammad Junaid Naseer, Childhood Tuberculosis Karachi Group, Mercedes Becerra, Farhana Amanullah

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization-Recommended Weight Band Doses and Formulations.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Meherunissa HamidGlobal Health Directorate, The Indus Health Network, Karachi, Sindh, Pakistan.ORCID 0000-0002-8569-304X
Meredith B BrooksDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States of America.
Falak MadhaniGlobal Health Directorate, The Indus Health Network, Karachi, Sindh, Pakistan.
Hassan AliGlobal Health Directorate, The Indus Health Network, Karachi, Sindh, Pakistan.
Mohammad Junaid NaseerGlobal Health Directorate, The Indus Health Network, Karachi, Sindh, Pakistan.
Childhood Tuberculosis Karachi Group
Mercedes BecerraDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States of America.
Farhana AmanullahGlobal Health Directorate, The Indus Health Network, Karachi, Sindh, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePakistan has a high pediatric burden of tuberculosis, but few studies describe the treatment experience of children with tuberculosis in Pakistan. We sought to identify risk factors for unsuccessful treatment outcomes in children with drug-susceptible tuberculosis identified in eight hospitals in Karachi, Pakistan.

designWe conducted a retrospective cohort study among children (<15 years old) treated with first-line anti-tuberculosis drugs for presumed or confirmed drug-susceptible tuberculosis between 2016 and 2017. We assessed risk factors for experiencing an unsuccessful treatment outcome through multivariable logistic regression analysis.

resultsIn total, 1,665 children initiated tuberculosis treatment, including 916 (55.0%) identified through intensified case finding. Unsuccessful treatment outcomes were experienced by 197 (11.8%) children, comprising 27 (1.6%) deaths, 16 (1.0%) treatment failures, and 154 (9.3%) lost to follow-up. An additional 47 (2.8%) children had outcomes not evaluable. In multivariable analysis, children 0-4 years old (OR: 1.80, 95% CI: 1.07-3.04), males (OR: 1.48, 95% CI: 1.04, 2.11), and those with bacteriologic confirmation of disease (OR: 3.39, 95% CI: 1.98, 5.80) had increased odds of experiencing an unsuccessful treatment outcome.

conclusionOur findings suggest a need to deploy strategies to identify children earlier in the disease process and point to the need for interventions tailored for young children once treatment is initiated.

Indexed as

AdolescentAge FactorsAntitubercular AgentsChildChild, PreschoolFemaleHumansInfantInfant, NewbornLogistic ModelsMaleMicrobial Sensitivity TestsMycobacterium tuberculosisPakistanRetrospective StudiesRisk FactorsAntitubercular Agents

Identifiers

PMID31553758
PMCPMC6760830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.